http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3018812-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40920cf7d4065ed9e7cb944410f4f51d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| filingDate | 2014-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0067672a7a50a974a90adcb42420fab6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b293ad25b73cad3c77e970648b6e68fc |
| publicationDate | 2015-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | FR-3018812-A1 |
| titleOfInvention | NOVEL INTERMEDIATE PHASE OF FORM A OF MAGNESIUM SALT DIHYDRATE OF AN OMEPRAZOLE ENANTIOMER |
| abstract | The present invention relates to an intermediate phase of form A of the magnesium salt dihydrate of an enantiomer of omeprazole, as well as to a process for the preparation thereof. The present invention also relates to a process for the preparation of the form A of the magnesium salt dihydrate of an enantiomer of omeprazole from said intermediate phase, as well as a crystal of form A obtained by this process, and its use in as a medicine. |
| priorityDate | 2014-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.